Latest Breaking News On - Halucenex life sciences inc - Page 1 : comparemela.com

Melodiol Global Health weighs asset sale with US-listed Panacea

Melodiol Global Health Ltd (ASX:ME1) is moving to streamline its portfolio and expand its North American footprint through an asset sale with US-listed.

United statesMelodiol global health ltdSierra sage herbsPanacea life science holdings incHalucenex life sciences incNorth americanPanacea life science holdingsHalucenex life sciencesEverblu capital

Creso Pharma Ltd has eyes on multi-million dollar functional mushroom product market

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) will soon have a slice of the multi-million dollar global functional mushroom market with the launch of a new.

United statesCreso pharmaSierra sage herbsHalucenex life sciences incCreso pharma ltdHalucenex life sciencesAmazon unitedWilliam layGood gooSouthern butter

Creso Pharma Ltd gains Supreme Court green light for Health House acquisition

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has received the green light from the Supreme Court of Western Australia to acquire 100% of Health House.

Creso pharmaCreso pharma ltdHalucenex life sciences incHealth house international ltdSupreme courtHealth houseWestern australiaHealth house internationalWilliam layHalucenex life sciencesPost traumatic stress disorder

Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings

Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
cannabisculture.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cannabisculture.com Daily Mail and Mail on Sunday newspapers.

Creso pharmaHalucenex life sciences incHalucenex life sciences

Creso Pharma Ltd s subsidiary Halucenex demonstrates potential of psilocybin to treat PTSD

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has received “promising” early results from its wholly owned psychedelics subsidiary Halucenex Life Sciences Inc. s.

Creso pharmaCreso pharma ltdHalucenex life sciences incHalucenex life sciencesClinical trial amendmentWilliam layStructured clinical interview